IGM Biosciences, Inc. - COM (IGMS)

Historical Portfolio Holders from Q3 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
21.6M
Holdings value Q3 2024
$357M
Value change Q3 2024
-$28.7M
Grand Portfolio weight change Q3 2024
0%
Number of holders
71
Number of buys Q3 2024
31
Number of sells Q3 2024
-43
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 21.6M $357M -$28.7M $16.54 72
2024 Q2 22.3M $153M -$7.04M $6.87 82
2024 Q1 22.8M $220M +$9.91M $9.65 85
2023 Q4 21.9M $182M -$4.91M $8.31 71
2023 Q3 22.3M $186M +$4.17M $8.35 78
2023 Q2 21.8M $201M +$34.1M $9.23 78
2023 Q1 17.8M $244M -$3.02M $13.74 74
2022 Q4 18M $306M +$887K $17.01 77
2022 Q3 17.7M $402M -$8.39M $22.74 90
2022 Q2 17.5M $316M -$24.2M $18.03 89
2022 Q1 18.2M $487M +$12.9M $26.73 93
2021 Q4 17.6M $517M +$7.33M $29.33 84
2021 Q3 16.9M $1.11B +$22.1M $65.76 106
2021 Q2 16.3M $1.36B -$130M $83.20 106
2021 Q1 18M $1.38B +$60M $76.69 110
2020 Q4 17.2M $1.52B +$223M $88.29 108
2020 Q3 14.7M $1.08B +$47.9M $73.81 93
2020 Q2 14M $1.02B +$55.8M $73.00 80
2020 Q1 13.3M $742M +$66.5M $56.15 61
2019 Q4 12.2M $463M +$92.4M $38.16 50
2019 Q3 10M $178M +$178M $17.75 33